BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8897926)

  • 1. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
    Décarie A; Raymond P; Gervais N; Couture R; Adam A
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1340-7. PubMed ID: 8897926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of enalaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischaemic rat heart.
    Lamontagne D; Nadeau R; Adam A
    Br J Pharmacol; 1995 Jun; 115(3):476-8. PubMed ID: 7582459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation.
    Raymond P; Drapeau G; Raut R; Audet R; Marceau F; Ong H; Adam A
    J Immunol Methods; 1995 Mar; 180(2):247-57. PubMed ID: 7714339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase N.
    Drapeau G; Chow A; Ward PE
    Peptides; 1991; 12(3):631-8. PubMed ID: 1656406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kininases and vascular responses to kinins.
    Babiuk C; Marceau F; St-Pierre S; Regoli D
    Eur J Pharmacol; 1982 Feb; 78(2):167-74. PubMed ID: 6122586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
    Matsumura Y; Maeda H; Kato H
    Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
    Drapeau G; deBlois D; Marceau F
    J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1.
    deBlois D; Bouthillier J; Marceau F
    Br J Pharmacol; 1991 May; 103(1):1057-66. PubMed ID: 1878745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phe8 psi(CH2-NH)Arg9]bradykinin, a B2 receptor selective agonist which is not broken down by either kininase I or kininase II.
    Drapeau G; Rhaleb NE; Dion S; Jukic D; Regoli D
    Eur J Pharmacol; 1988 Oct; 155(1-2):193-5. PubMed ID: 2907489
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitors and expression of des-Arg9-BK (kinin B1) receptors in vivo.
    Nwator IA; Whalley ET
    Eur J Pharmacol; 1989 Jan; 160(1):125-32. PubMed ID: 2540986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin.
    Martins DT; Fior DR; Nakaie CR; Lindsey CJ
    Br J Pharmacol; 1991 Aug; 103(4):1851-6. PubMed ID: 1655143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of the up-regulated responses to des-Arg9-bradykinin in vivo and in vitro.
    deBlois D; Bouthillier J; Marceau F
    Immunopharmacology; 1989; 17(3):187-98. PubMed ID: 2788631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1986 Jun; 35(12):1951-6. PubMed ID: 3013204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of various rat plasma peptidases to kinin hydrolysis.
    Ishida H; Scicli AG; Carretero OA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of [3H]des-Arg9-BK to rabbit anterior mesenteric vein.
    Barabé J; Babiuk C; Regoli D
    Can J Physiol Pharmacol; 1982 Dec; 60(12):1551-5. PubMed ID: 6131738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sodium balance on urinary excretion of immunoreactive kinins in rats.
    Barabé J; Huberdeau D; Bernoussi A
    Am J Physiol; 1988 Apr; 254(4 Pt 2):F484-91. PubMed ID: 3354684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinin receptors and angiotensin converting enzyme in rabbits basilar arteries.
    Whalley ET; Fritz H; Geiger R
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):296-301. PubMed ID: 6141533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.
    DelBel EA; Padovan AP; Padovan GJ; Sellinger OZ; Martins AR
    Cell Mol Neurobiol; 1989 Sep; 9(3):379-400. PubMed ID: 2558804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective expression of des-Arg9-BK sensitive (B1) receptors in vivo and in vitro by angiotensin converting enzyme inhibitors.
    Whalley ET; Nwator IA
    Adv Exp Med Biol; 1989; 247A():185-9. PubMed ID: 2557739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.